A. Larkin
Impact in
-
- Drug Transport and Resistance Mechanisms
- Cytokine Signaling Pathways and Interactions
- Pancreatic and Hepatic Oncology Research
-
- NF-κB Signaling Pathways
Papers in
- Oncology 11
- Drug Transport and Resistance Mechanisms 7
- HER2/EGFR in Cancer Research 3
- Pancreatic and Hepatic Oncology Research 2
- Cancer Treatment and Pharmacology 1
- Cytokine Signaling Pathways and Interactions 1
-
- Protein Degradation and Inhibitors 1
- Co-authors
- Donna J. Thuerauf (1 shared paper)Christopher C. Glembotski (1 shared paper)Catherine A. Andrews (1 shared paper)Patrick M. McDonough (1 shared paper)Martin Clynes (10 shared papers)Susan Kennedy (6 shared papers)Lorraine O’Driscoll (7 shared papers)John Crown (4 shared papers)
- Journals
- Journal of Clinical Oncology (2 papers)Journal of Clinical Pathology (1 paper)British Journal of Cancer (1 paper)Journal of Biological Chemistry (1 paper)European Journal of Cancer (1 paper)
- Partner nations
- IrelandUnited StatesNetherlands
In The Last Decade
A. Larkin
11 papers receiving 545 citations
Peers
Comparison fields: 5 of 84
- Oncology 225
- Cancer Research 102
- Immunology 110
- Molecular Biology 288
- Toxicology 13
Countries citing papers authored by A. Larkin
This map shows the geographic impact of A. Larkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Larkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Larkin more than expected).
Fields of papers citing papers by A. Larkin
This network shows the impact of papers produced by A. Larkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Larkin. The network helps show where A. Larkin may publish in the future.
Co-authors
The 25 scholars most cited alongside A. Larkin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 306 | |
| 2 | MDR1/P-glycoprotein and MRP-1 drug efflux pumps in pancreatic carcinoma. | 2007 | 52 |
| 3 | 2006 | 49 | |
| 4 | MDR1/P-glycoprotein and MRP-1 mRNA and protein expression in non-small cell lung cancer. | 2007 | 34 |
| 5 | 2010 | 32 | |
| 6 | 1997 | 25 | |
| 7 | Expression and prognostic relevance of Mcl-1 in breast cancer. | 2004 | 19 |
| 8 | 1997 | 17 | |
| 9 | 2002 | 13 | |
| 10 | 2001 | 6 | |
| 11 | 2010 | 1 | |
| 12 | 2011 | 0 |
About A. Larkin
A. Larkin is a scholar working on Oncology, Molecular Biology, Surgery, Radiology, Nuclear Medicine and Imaging and Organic Chemistry, having authored 12 papers that have together received 554 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (7 papers), HER2/EGFR in Cancer Research (3 papers), Pancreatic and Hepatic Oncology Research (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers), Cancer Treatment and Pharmacology (1 paper), Cytokine Signaling Pathways and Interactions (1 paper) and Protein Degradation and Inhibitors (1 paper). The work is most often cited by research in Oncology (225 citations), Cancer Research (102 citations), Immunology (110 citations), Molecular Biology (288 citations) and Toxicology (13 citations). A. Larkin has collaborated with scholars based in Ireland, United States and Netherlands. Frequent co-authors include Donna J. Thuerauf, Christopher C. Glembotski, Catherine A. Andrews, Patrick M. McDonough, Martin Clynes, Susan Kennedy, Lorraine O’Driscoll, John Crown, Robert O’Connor and E Morán. Their work appears in journals such as Journal of Clinical Oncology, Journal of Clinical Pathology, British Journal of Cancer, Journal of Biological Chemistry and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.